These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36868848)

  • 1. Long-term outcomes of moyamoya disease versus atherosclerosis-associated moyamoya vasculopathy using high-resolution MR vessel wall imaging.
    Lu M; Zhang H; Liu S; Liu D; Peng P; Hao F; Yuan F; Liu Y; Sheng F; Zhang L; Zhao X; He Y; Han C; Cai J
    J Neurol Neurosurg Psychiatry; 2023 Jul; 94(7):567-574. PubMed ID: 36868848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encephaloduroarteriosynangiosis for pediatric moyamoya disease: long-term follow-up of 100 cases at a single center.
    Zhang Y; Bao XY; Duan L; Yang WZ; Li DS; Zhang ZS; Han C; Zhao F; Zhang Q; Wang QN
    J Neurosurg Pediatr; 2018 Aug; 22(2):173-180. PubMed ID: 29856299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encephaloduroarteriosynangiosis for hemorrhagic moyamoya disease: long-term outcome of a consecutive series of 95 adult patients from a single center.
    Wang QN; Bao XY; Zhang Y; Zhang Q; Li DS; Duan L
    J Neurosurg; 2019 Jun; 130(6):1898-1905. PubMed ID: 29999465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encephaloduroarteriosynangiosis for adult intracranial arterial steno-occlusive disease: long-term single-center experience with 107 operations.
    Gonzalez NR; Dusick JR; Connolly M; Bounni F; Martin NA; Van de Wiele B; Liebeskind DS; Saver JL
    J Neurosurg; 2015 Sep; 123(3):654-61. PubMed ID: 26067617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 7.0- and 3.0-T MRI and MRA in ischemic-type moyamoya disease: preliminary experience.
    Deng X; Zhang Z; Zhang Y; Zhang D; Wang R; Ye X; Xu L; Wang B; Wang K; Zhao J
    J Neurosurg; 2016 Jun; 124(6):1716-25. PubMed ID: 26544772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexisting diseases of moyamoya vasculopathy.
    Wei YC; Liu CH; Chang TY; Chin SC; Chang CH; Huang KL; Chang YJ; Peng TI; Lee TH
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1344-50. PubMed ID: 24468071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution MR imaging of the arterial wall in moyamoya disease.
    Yuan M; Liu ZQ; Wang ZQ; Li B; Xu LJ; Xiao XL
    Neurosci Lett; 2015 Jan; 584():77-82. PubMed ID: 25459282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
    Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
    J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult moyamoya-atherosclerosis syndrome: Clinical and vessel wall imaging features.
    Han C; Li ML; Xu YY; Ye T; Xie CF; Gao S; Duan L; Xu WH
    J Neurol Sci; 2016 Oct; 369():181-184. PubMed ID: 27653886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wound healing complications after revascularization for moyamoya vasculopathy with reference to different skin incisions.
    Acker G; Schlinkmann N; Fekonja L; Grünwald L; Hardt J; Czabanka M; Vajkoczy P
    Neurosurg Focus; 2019 Feb; 46(2):E12. PubMed ID: 30717062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moyamoya disease versus moyamoya syndrome: comparison of presentation and outcome in 338 hemispheres.
    Feghali J; Xu R; Yang W; Liew JA; Blakeley J; Ahn ES; Tamargo RJ; Huang J
    J Neurosurg; 2020 Nov; 133(5):1441-1449. PubMed ID: 31585423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ipsilateral late stroke after revascularization surgery for patients with Moyamoya disease.
    Araki Y; Yokoyama K; Uda K; Kanamori F; Mamiya T; Nishihori M; Sumitomo M; Okamoto S; Izumi T
    Acta Neurochir (Wien); 2021 May; 163(5):1493-1502. PubMed ID: 33624115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
    Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
    J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Genetic Risk Factors of Long-Term Outcomes after Encephaloduroarteriosynangiosis in Moyamoya Disease in China.
    Wang X; Zhang Z; Wang Y; Zou Z; Ta N; Hao F; Shang M; Li D; Zeng F; Han C; Nie F; Bao X; Yang Y; Wang H; Liang M; Yang R; Ou L; Wen L; Yang Z; Liu W; Duan L
    J Stroke Cerebrovasc Dis; 2021 Jul; 30(7):105847. PubMed ID: 33992965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution combined arterial spin labeling MR for identifying cerebral arterial stenosis induced by moyamoya disease or atherosclerosis.
    Ya J; Zhou D; Ding J; Ding Y; Ji X; Yang Q; Meng R
    Ann Transl Med; 2020 Feb; 8(4):87. PubMed ID: 32175380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
    Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
    Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy and delivery in moyamoya vasculopathy: experience of a single European institution.
    Acker G; Czabanka M; Schmiedek P; Vajkoczy P
    Neurosurg Rev; 2018 Apr; 41(2):615-619. PubMed ID: 28921308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
    Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
    J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. dl-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score-matched analysis.
    Li Z; Lu J; Ma L; Wu C; Xu Z; Chen X; Ye X; Wang R; Zhao Y
    J Neurosurg; 2020 Feb; 132(2):421-433. PubMed ID: 30771781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.